Camille L. Bedrosian, Officer: Amylyx Pharmaceuticals AMLX Planned sale · Filed 09/11

Trade details

Type: Planned sale notice
Stock: Amylyx Pharmaceuticals AMLX
Person: Camille L. BedrosianOfficer
Planned sale date: 26/09/10
Filed: 26/09/11

3.6% of shares outstanding to be sold

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/11~10/10

Camille L. Bedrosian's recent trades

Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$5.8M
64,540 sh
$5.8M
Filed 03/04
Traded 03/04
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/04
Traded 03/02
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$3.2M
35,460 sh
$3.2M
Filed 03/03
Traded 03/03
Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/02
Traded 03/02
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.4K
6,580 sh
$94.4K
Filed 25/12/03
Traded 25/12/01